A study published in November in Nature Communications found that antihypertensive treatment prevents more serious cardiovascular events than it causes serious falls, even among older, frail patients.
The research, led by the University of Oxford’s Nuffield Department of Primary Care Health Sciences, analyzed anonymized health records from 5,578,002 patients aged 40 and older in England’s Clinical Practice Research Datalink between 1998 and 2018, McKnight’s Long-Term Care News reported.
The team developed a cardiovascular risk calculator called STRATIFY-CVD and combined it with existing models for medication-related side effects and clinical-trial evidence to estimate the balance of benefits and harms over a 10-year period.
In the validation cohort of 3,805,366 patients, 250,116 people — 6.6% — experienced a major cardiovascular event, defined as nonfatal myocardial infarction or stroke leading to hospital admission or any cardiovascular death, McKnight’s reported. Across the overall population, the model predicted that treating 1,000 patients for 10 years would prevent approximately eight serious cardiovascular events while causing around two serious falls.

The benefit–harm balance favored treatment even in patients typically considered vulnerable. By comparison, treating 1,000 fit men in their 60s with no cardiovascular history would prevent 12 events and cause one serious fall.
The trade-offs were less favorable for other adverse outcomes. For fainting and acute kidney injury, the benefits and harms were more finely balanced, MedicalXpress reported.
The study was funded by the Wellcome Trust and the National Institute for Health and Care Research, Mirage News reported.
STRATIFY-CVD estimates a person’s likelihood of a serious cardiovascular event over five to 10 years using routinely collected NHS records, incorporating age, medical history and existing conditions. The researchers combined those predictions with side-effect models and trial evidence to produce individualized benefit–harm estimates — a step toward the personalized approach Sheppard described.
The University of Oxford, where the Nuffield Department of Primary Care Health Sciences is based, is the oldest university in the English-speaking world, with evidence of teaching as early as 1096. It operates Oxford University Press, the largest university press in the world, and the Ashmolean Museum, the world’s oldest university museum.
The findings were published November 2024 in Nature Communications.
Worth a look